Literature DB >> 10454565

Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases.

I Blomberg1, I Hoffmann.   

Abstract

Human Cdc25 phosphatases play important roles in cell cycle regulation by removing inhibitory phosphates from tyrosine and threonine residues of cyclin-dependent kinases. Three human Cdc25 isoforms, A, B, and C, have been discovered. Cdc25B and Cdc25C play crucial roles at the G(2)/M transition. In the present study, we have investigated the function of human Cdc25A phosphatase. Cell lines that express human Cdc25A in an inducible manner have been generated. Ectopic expression of Cdc25A accelerates the G(1)/S-phase transition, indicating that Cdc25A controls an event(s) that is rate limiting for entry into S phase. Furthermore, we carried out a detailed analysis of the expression and activation of human Cdc25A. Activation of endogenous Cdc25A occurs during late G(1) phase and increases in S and G(2) phases. We further demonstrate that Cdc25A is activated at the same time as cyclin E- and cyclin A-dependent kinases. In vitro, Cdc25A dephosphorylates and activates the cyclin-Cdk complexes that are active during G(1). Overexpression of Cdc25A in the inducible system, however, leads to a premature activation of both cyclin E-Cdk2 and cyclin A-Cdk2 complexes, while no effect of cyclin D-dependent kinases is observed. Furthermore, Cdc25A overexpression induces a tyrosine dephosphorylation of Cdk2. These results suggest that Cdc25A is an important regulator of the G(1)/S-phase transition and that cyclin E- and cyclin A-dependent kinases act as direct targets.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454565      PMCID: PMC84557          DOI: 10.1128/MCB.19.9.6183

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases.

Authors:  P Saha; Q Eichbaum; E D Silberman; B J Mayer; A Dutta
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

3.  An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells.

Authors:  A Nagata; M Igarashi; S Jinno; K Suto; H Okayama
Journal:  New Biol       Date:  1991-10

4.  Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement.

Authors:  G Draetta; D Beach
Journal:  Cell       Date:  1988-07-01       Impact factor: 41.582

5.  cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2.

Authors:  J Gautier; M J Solomon; R N Booher; J F Bazan; M W Kirschner
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

6.  p55CDC25 is a nuclear protein required for the initiation of mitosis in human cells.

Authors:  J B Millar; J Blevitt; L Gerace; K Sadhu; C Featherstone; P Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

7.  Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins.

Authors:  K Galaktionov; D Beach
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

8.  Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.

Authors:  Y Gu; J Rosenblatt; D O Morgan
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

9.  Phosphorylation and activation of human cdc25-C by cdc2--cyclin B and its involvement in the self-amplification of MPF at mitosis.

Authors:  I Hoffmann; P R Clarke; M J Marcote; E Karsenti; G Draetta
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

10.  Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

Authors:  C H McGowan; P Russell
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  88 in total

1.  Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.

Authors:  E Santoni-Rugiu; J Falck; N Mailand; J Bartek; J Lukas
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Protein phosphorylation and protein phosphatases. De Panne, Belgium, September 19-24, 1999.

Authors:  S Zolnierowicz; M Bollen
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

3.  Cdc25B functions as a novel coactivator for the steroid receptors.

Authors:  Z Q Ma; Z Liu; E S Ngan; S Y Tsai
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase.

Authors:  M S Chen; J Hurov; L S White; T Woodford-Thomas; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

5.  Dual mode of degradation of Cdc25 A phosphatase.

Authors:  Maddalena Donzelli; Massimo Squatrito; Dvora Ganoth; Avram Hershko; Michele Pagano; Giulio F Draetta
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

6.  Compound library development guided by protein structure similarity clustering and natural product structure.

Authors:  Marcus A Koch; Lars-Oliver Wittenberg; Sudipta Basu; Duraiswamy A Jeyaraj; Eleni Gourzoulidou; Kerstin Reinecke; Alex Odermatt; Herbert Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-17       Impact factor: 11.205

Review 7.  Evolution of networks and sequences in eukaryotic cell cycle control.

Authors:  Frederick R Cross; Nicolas E Buchler; Jan M Skotheim
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-27       Impact factor: 6.237

Review 8.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

Review 9.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

10.  SIRT6 inhibits colorectal cancer stem cell proliferation by targeting CDC25A.

Authors:  Wenguang Liu; Manwu Wu; Hechun Du; Xiaoliang Shi; Tao Zhang; Jie Li
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.